Sources :
(1) Ju, Q., Tao, T., Hu, T., Karadağ, A., Al-Khuzaei, S., & Chen, W. (2017). Sex hormones and acne.. Clinics in dermatology, 35 2, 130-137.
(2)Tehrani, R., Behboudi-Gandevani, S., Yarandi, B., Naz, S., & Carmina, E. (2020). Prevalence of acne vulgaris among women with polycystic ovary syndrome: a systemic review and meta-analysis. Gynecological Endocrinology, 37, 392 - 405.
(3) Brown, J., Kives, S., & Akhtar, M. (2012). Progestagens and anti-progestagens for pain associated with endometriosis.. The Cochrane database of systematic reviews, 3, CD002122.
(4) Motosko, C., Zakhem, G., Pomeranz, M., & Hazen, A. (2018). Acne: a side‐effect of masculinizing hormonal therapy in transgender patients. British Journal of Dermatology, 180.
(5) Rocha, M., & Bagatin, E. (2018). Adult-onset acne: prevalence, impact, and management challenges. Clinical, Cosmetic and Investigational Dermatology, 11, 59 - 69.
(6) Cantrell, W., Easley, L., & Squittieri, K. (2024). Steroids Used to Treat Acne Vulgaris: A Review of Efficacy, Safety, and Clinical Considerations.. Journal of drugs in dermatology : JDD, 23 6, 404-409.
(7) Barbieri, J. (2020). A New Class of Topical Acne Treatment Addressing the Hormonal Pathogenesis of Acne. JAMA dermatology.